Second, tumour heterogeneity has been shown to confound measurements of PD-L1 expression in lung cancer [11,12] and may play a role in our analysis of VISTA accordingly, as STS are characterised by substantial intratumoral heterogeneity with distinguishable areas of differentiation [13] co-existing in one tumour. The gene discussed is CD274; the disease is lung carcinoma.